Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Week Results of an Uncontrolled Open-Label Clinical Study

Autor: Michels, Stephan, Rosenfeld, Philip J., Puliafito, Carmen A., Marcus, Erin N., Venkatraman, Anna S.
Zdroj: In Ophthalmology 2005 112(6):1035-1047
Databáze: ScienceDirect